Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Flagship Biotech International Private Limited, is an unlisted private company incorporated on 09 August, 2011. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 1.08 cr and the total paid-up capital is INR 13.26 lac.
Flagship Biotech International's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2021. It's EBITDA has increased by 85.43% over the previous year. At the same time, it's book networth has increased by 24.62%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2021 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Axis Bank Limited
No. of Loans: 1
Total Amount : 4.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 3.2 cr
RBL Bank Limited
No. of Loans: 1
Total Amount : 0.3 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Kedar Avinash Vidwans
Shareholder
|
03554442 | 13 years |
Director | Shailesh Dilipbhai Patel
Shareholder
|
03554471 | 13 years |
Director | Tejaswini Kedar Vidwans
Shareholder
|
03560823 | 13 years |
Director | Dipaben Shailesh Patel
Shareholder
|
03560824 | 13 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SUSHMA TECHNOLOGY PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
FLAGSHIP INGREVIA PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
BRIGID WELLNESS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
FLAGSHIP BIOTECH FOUNDATION |
Active
|
1.0 L | 4 | Maharashtra |
BLUE PARADIGM PHARMACEUTICALS LLP |
Active
|
1.0 L | 1 | Maharashtra |
DIVINE LABORATORIES PVT. LTD. |
Active
|
40.0 L | 2 | Gujarat |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
DIVINE LABORATORIES PVT. LTD. | Gujarat | 1994 | ₹ 40.0 L |
The incorporation date of FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED is 09 August, 2011
The authorized share capital of FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED is INR ₹ 1.1 Cr.
The paid-up capital of FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED is INR ₹ 13.3 L.
The registered address of FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED is OFFICE NO 1302, 13TH FLOOR, PLOT NO A1, SECTOR 1, MILLENNIUM BUSINESS PARK, MAHAPE NAVI MUMBAI Thane Maharashtra - 400710
The CIN number of FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED is U74120MH2011PTC220700.